The metropolitan Detroit area is home to a population that is ethnically and culturally diverse, and the Population Studies and Prevention program brings together faculty with a variety of scholarly interests whose research is based on this diversity. The Program has developed three major themes: 1) Cancer Etiology and Prognosis, with a research emphasis on population-based studies of cancer etiology and race/ethnicity related health disparities; 2) Prevention, with a research emphasis on studies designed to prevent and/or control the development of cancer within this population; and 3) Communication and Behavioral Oncology, with a research emphasis on understanding the role of communication in determining how best to change and improve health behavior. Our population-based studies focus on the interface between genetic and environmental exposures and their roles in the subsequent development of cancer and survival from this disease. These studies aim to define the contribution of familial risk, describe patterns of inheritance and discover susceptibility genes for cancer. Modification of risk by diet, smoking and other environmental factors is also explored. Our major research emphasis in prevention is on understanding the role, at a molecular level, that nutrition plays in the prevention of cancer. Research focuses on the preventive effects of soy isoflavones, lycopene, folic acid, tea polyphenols, zinc, increased fruits and vegetables, and a low fat diet in a variety of cancers. The effects of these interventions on molecular targets such as NF-kB, AKT, EGFR and IL-2 are currently under investigation, with basic science work translated into chemoprevention trials when appropriate. As we identify risk factors for disease, behavioral intervention strategies and new chemopreventive agents, work in the Communication and Behavioral Oncology area emphasizes how to most effectively communicate these findings to protect the health of our diverse population.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
5P30CA022453-25
Application #
7310827
Study Section
Subcommittee G - Education (NCI)
Project Start
Project End
Budget Start
2005-12-01
Budget End
2006-11-30
Support Year
25
Fiscal Year
2006
Total Cost
$19,991
Indirect Cost
Name
Wayne State University
Department
Type
DUNS #
001962224
City
Detroit
State
MI
Country
United States
Zip Code
48202
Shah, Seema; Brock, Ethan J; Jackson, Ryan M et al. (2018) Downregulation of Rap1Gap: A Switch from DCIS to Invasive Breast Carcinoma via ERK/MAPK Activation. Neoplasia 20:951-963
An, Mingrui; Wu, Jing; Zhu, Jianhui et al. (2018) Comparison of an Optimized Ultracentrifugation Method versus Size-Exclusion Chromatography for Isolation of Exosomes from Human Serum. J Proteome Res 17:3599-3605
Yu, Chunsong; An, Myunggi; Jones, Evan et al. (2018) Targeting Suppressive Oligonucleotide to Lymph Nodes Inhibits Toll-like Receptor-9-Mediated Activation of Adaptive Immunity. Pharm Res 35:56
Kariburyo, Furaha; Wang, Yuexi; Cheng, I-Ning Elaine et al. (2018) Observation versus treatment among men with favorable risk prostate cancer in a community-based integrated health care system: a retrospective cohort study. BMC Urol 18:55
Thakur, Manish K; Heilbrun, Lance; Dobson, Kimberlee et al. (2018) Phase I Trial of the Combination of Docetaxel, Prednisone, and Pasireotide in Metastatic Castrate-Resistant Prostate Cancer. Clin Genitourin Cancer 16:e695-e703
Feldmann, Daniel P; Cheng, Yilong; Kandil, Rima et al. (2018) In vitro and in vivo delivery of siRNA via VIPER polymer system to lung cells. J Control Release 276:50-58
Vaishampayan, Ulka (2018) Advantages and Adversities of the Weighted Toxicity Score. Clin Cancer Res 24:4918-4920
Wang, Zhaoxian; Sau, Samaresh; Alsaab, Hashem O et al. (2018) CD44 directed nanomicellar payload delivery platform for selective anticancer effect and tumor specific imaging of triple negative breast cancer. Nanomedicine 14:1441-1454
Ravindra, Manasa; Wilson, Mike R; Tong, Nian et al. (2018) Fluorine-Substituted Pyrrolo[2,3- d]Pyrimidine Analogues with Tumor Targeting via Cellular Uptake by Folate Receptor ? and the Proton-Coupled Folate Transporter and Inhibition of de Novo Purine Nucleotide Biosynthesis. J Med Chem 61:4228-4248
Kim, Seongho; Wong, Weng Kee (2018) Extended two-stage adaptive designs with three target responses for phase II clinical trials. Stat Methods Med Res 27:3628-3642

Showing the most recent 10 out of 826 publications